A leading center for practice-changing discovery and comprehensive cancer treatment, the Sidney Kimmel Cancer Center of the Thomas Jefferson University has been known as a Designated Center by the National Cancer Institute since 1996, and is one of only 69 institutions in the nation to hold this prestigious recognition. SKCC is committed to delivering the most advanced, personalized cancer care, made possible through their scientific discoveries and breakthroughs in detecting and treating cancer. SKCC provides access to advanced clinical trials and novel treatment strategies throughout the Greater Delaware Valley. SKCC is routinely ranked amongst the top hospitals for cancer care in the United States by US News & World Report, the multi-disciplinary teams at SKCC bring together specialists for treatment planning, which results in some of the highest survival rates in the nation.
Andrew Aplin Named First Recipient of Kalbach-Newton Professorship in Cancer Research
New Recommendations Provide Guidance on Genetic Counseling & Testing for Hereditary Prostate Cancer
Scott Waldman Named a 2017 Fellow of the National Academy of Inventors
Sidney Kimmel Cancer Center Researchers Receive $1.3 Million from Falk Trust
Researchers Find Breakthroughs in Understanding Genetic Basis of Aggressive Prostate Cancer